Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
- 3 February 2025
- journal article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (4) , e31531
Abstract
Bidirectional relationships exist among sickle cell disease (SCD), sleep‐disordered breathing (SDB), and hydroxyurea therapy, and this complex interplay poses challenges to research attempting to elucidate causal mechanisms and determine therapeutic targets. We therefore set out to study all three components of this clinical triad simultaneously (SCD, SDB, and hydroxyurea therapy), documenting correlations and suggesting underlying pathophysiological mechanisms. Hydroxyurea therapy was associated with improved SDB and with decreased inflammation, implicating the anti‐inflammation effects of hydroxyurea as a plausible mechanism driving these correlations. These results underscore the need for longitudinal studies to elucidate causal relationships.Keywords
This publication has 18 references indexed in Scilit:
- The interplay of sleep disordered breathing, nocturnal hypoxemia, and endothelial dysfunction in sickle cell diseaseProgress in Pediatric Cardiology, 2022
- Sleep Apnea Screening in Children With Sickle Cell AnemiaJournal of Pediatric Hematology/Oncology, 2022
- Screening for Obstructive Sleep Apnea in Children With Sickle Cell Disease: A Pilot StudyThe Laryngoscope, 2020
- Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthoodPediatric Blood & Cancer, 2018
- Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apneaSleep and Breathing, 2017
- Sleep-disordered breathing and nocturnal hypoxemia in young adults with sickle cell diseaseSleep Medicine, 2016
- Inflammatory targets of therapy in sickle cell diseaseTranslational Research, 2016
- Hemoglobinopathies and sleep – The road less traveledSleep Medicine Reviews, 2015
- Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH TrialPediatric Blood & Cancer, 2015
- Systemic inflammation impairs respiratory chemoreflexes and plasticityRespiratory Physiology & Neurobiology, 2011